Financials
- Market Capitalization 518.87 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry Биотехнологии
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Related tickers
| # | Название | Цена | 24ч % | 7д % | 1М % | 1Г % | Капитализация | Последние 7 дней | |
|---|---|---|---|---|---|---|---|---|---|
| 2885 | OVID Ovid Therapeutics Inc. - Common Stock | 2.68 USD | -4.29% | -4.96% | +20.72% | +114.40% | 523.40 M USD | ||
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.00 USD | -0.99% | -12.02% | +3.09% | +54.64% | 519.43 M USD | ||
| 2940 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -5.57% | +18.67% | -23.67% | 479.78 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.23 USD | -1.07% | -2.02% | +12.97% | +12.97% | 473.84 M USD |